Tim Tyson
Direktor/Vorstandsmitglied bei SYROS PHARMACEUTICALS, INC.
Vermögen: 148 871 $ am 31.01.2020
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Steve Hoffman | M | 61 |
Tyme, Inc.
 Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 13 Jahre |
| Nancy Simonian | M | 63 | 12 Jahre | |
| Michael Demurjian | M | 60 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 9 Jahre |
| Richard Cunningham | M | 54 |
Icagen-T, Inc.
 Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ. | 3 Jahre |
| Donald DeGolyer | M | 63 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 6 Jahre |
| Gerald H. Sokol | M | 81 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 10 Jahre |
| Keith Lyon | M | - |
TriRx Pharmaceutical Services LLC
 TriRx Pharmaceutical Services LLC Medical/Nursing ServicesHealth Services TriRx Pharmaceutical Services LLC operates contract development and manufacturing organization which serving the biopharmaceutical market. The company was founded by Keith Lyon and Timothy C. Tyson and is headquartered in Norwalk, CT. | - |
| Conley Chee | M | 54 | 3 Jahre | |
| Richard Young | M | 70 | 13 Jahre | |
| Pat LePore | M | 69 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 9 Jahre |
| Peter Wirth | M | 73 | 7 Jahre | |
| Andrew Oh | M | 53 | 2 Jahre | |
| S. Gail Eckhardt | M | 66 | 4 Jahre | |
| Mark Korb | M | 57 |
Icagen-T, Inc.
Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ.
Icagen, Inc.
 Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | - |
| Jim Scandura | M | - |
TriRx Pharmaceutical Services LLC
TriRx Pharmaceutical Services LLC Medical/Nursing ServicesHealth Services TriRx Pharmaceutical Services LLC operates contract development and manufacturing organization which serving the biopharmaceutical market. The company was founded by Keith Lyon and Timothy C. Tyson and is headquartered in Norwalk, CT. | - |
| Deborah Dunsire | M | 61 | 3 Jahre | |
| Karen Hunady | F | - | 2 Jahre | |
| James Ford | M | - | 29 Jahre | |
| Marsha Fanucci | F | 70 | 9 Jahre | |
| Srini Akkaraju Akkaraju | M | 56 | 7 Jahre | |
| Jason Haas | M | 56 | 3 Jahre | |
| Lisa Roberts | F | - | 12 Jahre | |
| Graham Rivers | M | - | 26 Jahre | |
| Kristin Stephens | F | 51 | - | |
| Michael Taglich | M | 57 |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | - |
| Lori Peterson | F | - |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | - |
| David Roth | M | 61 | 9 Jahre | |
| Nathan H. Zahler | M | - |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | 11 Jahre |
| Clive P. Kabatznik | M | 66 |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | - |
| David Redfern | M | 57 | 30 Jahre | |
| Gerald Quirk | M | 56 | - | |
| Douglas S. Krafte | M | 64 |
Icagen-T, Inc.
Icagen-T, Inc. BiotechnologyHealth Technology Icagen-T, Inc. engages in development of pharmaceutical drugs. The company is headquartered in Oro Valley, AZ. | - |
| John M. Rothman | M | 75 | 4 Jahre | |
| Douglas Giordano | M | 61 |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | 13 Jahre |
| Edward Roffman | M | 74 |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | 13 Jahre |
| Shetaun Deering | F | - |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC. | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Richard Sykes | M | 79 |
Glaxo Wellcome Plc
| 7 Jahre |
| Tommy Thompson | M | 81 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 5 Jahre |
| J. Pearson | M | 64 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 2 Jahre |
| Peter R. Dolan | M | 68 | 18 Jahre | |
| Charles A. Heimbold | M | - | 20 Jahre | |
| James Biehl | M | 60 | 5 Jahre | |
| Julian Heslop | M | 70 |
Glaxo Wellcome Plc
| 13 Jahre |
| Albert Medwar | M | - | 11 Jahre | |
| Ben Taylor | M | 46 | 3 Jahre | |
| Charles Bramlage | M | 63 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 9 Jahre |
| Douglas Michels | M | 66 | 4 Jahre | |
| John E. Celentano | M | 64 | 31 Jahre | |
| Paul Sturman | M | 63 | - | |
| Niraj Vasisht | M | 61 | 13 Jahre | |
| Robert Dickey | M | 68 |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | 2 Jahre |
| Jonathan Eckard | M | 50 | 5 Jahre | |
| William Louv | M | - | 21 Jahre | |
| David P. Carberry | M | 71 | 5 Jahre | |
| William B. Stone | M | 81 | 16 Jahre | |
| Rosemary Crane | F | 64 | 20 Jahre | |
| Robert J. DiVasto | M | 68 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ.
Glaxo Wellcome Plc
| 15 Jahre |
| Akber Pabani | M | 58 | - | |
| Peter Greenleaf | M | 54 | 4 Jahre | |
| Charles Bancroft | M | 65 | 36 Jahre | |
| Mary Coleman | F | - | - | |
| William Mark Watson | M | 73 | 5 Jahre | |
| Barry I. Feinberg | M | 68 | 4 Jahre | |
| Stephana Patton | M | - | 2 Jahre | |
| James D. Darnley | M | - | 1 Jahre | |
| Herm Cukier | M | 57 | 2 Jahre | |
| Michele Korfin | F | 53 | 2 Jahre | |
| Kevin Kotler | M | 53 | 4 Jahre | |
| Mark W. Durand | M | 64 | 17 Jahre | |
| Harrison Bains | M | 80 | 16 Jahre | |
| Michael H. Baker | M | - |
Jacksonville State University
| 6 Jahre |
| Samuel Sears | M | 80 | 7 Jahre | |
| Lawrence Hamilton | M | 66 | 8 Jahre | |
| Béatrice J. Cazala | F | 67 | 32 Jahre | |
| Robert Rosewell Chai-Onn | M | 52 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 6 Jahre |
| Mark Alles | M | 64 | 4 Jahre | |
| Phillip Sharp | M | 79 | 10 Jahre | |
| Thomas D'Alonzo | M | 80 | 5 Jahre | |
| Michèle Barzach | M | - | 7 Jahre | |
| Michael A. Griffith | M | 66 |
Aptuit LLC
 Aptuit LLC Miscellaneous Commercial ServicesCommercial Services Aptuit LLC engages in the development of pharmaceutical and biotechnological products. Its offerings include drug design and discovery, preclinical biosciences, API development and manufacture, solid state chemistry, solid and oral dosage form development and manufacture, integrated drug discovery and drug development, Aptuit INDiGO, and physical and analytical chemistry services. The company was founded in December 2004 and is headquartered in Greenwich, CT. | 4 Jahre |
| Geoffrey Glass | M | 50 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 4 Jahre |
| Amir Nashat | M | 51 | 8 Jahre | |
| Todd Davis | M | 63 | 4 Jahre | |
| Alex Howarth | M | 55 | 10 Jahre | |
| Roger L. Bruley | M | - |
US Military Academy
| 4 Jahre |
| Samuel Moed | M | 62 | 32 Jahre | |
| William T. Comer | M | 85 | 9 Jahre | |
| H. Eric C. Peitz | M | - |
US Military Academy
| 4 Jahre |
| Jonathan Faith | M | - |
US Military Academy
| 4 Jahre |
| Patrick Colin | M | - | - | |
| Bruce Frasier | M | - |
US Military Academy
| 4 Jahre |
| Jill DeSimone | F | 68 | 32 Jahre | |
| Tom Landwermeyer | M | - |
US Military Academy
| 4 Jahre |
| Charles M. Urbain | M | 70 | 14 Jahre | |
| Donald Hayden | M | 68 | 25 Jahre | |
| Herman Bulls | M | 68 |
US Military Academy
| 4 Jahre |
| George Zavoico | M | - | - | |
| Claude Nicaise | M | 71 | 25 Jahre | |
| Raymond T. Keane | M | 65 | 20 Jahre | |
| Robert E. Allen | M | - | 21 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 92 | 92,00% |
| Vereinigtes Königreich | 9 | 9,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
